Multiple Sclerosis Therapy
Multiple Sclerosis Therapy is a therapeutic intervention strategy within the domain of immunomodulatory drug therapy that specifically targets the modulation of immune responses to mitigate neuroinflammation and decelerate disease progression in individuals with multiple sclerosis.
8K
Publications
507K
Citations
30.9K
Authors
5.4K
Institutions
Publications per year
2017–2026
2.5K
8K
1–5 of 8K
30.9K
88
h-index
68
h-index
61
h-index
59
h-index
57
h-index
1–5 of 30.9K
5.4K
University Hospital of Basel
Basel, Switzerland
83 h-index
654 publications
116.7K citations
University of California, San Francisco
San Francisco, United States
78 h-index
655 publications
98.5K citations
Cleveland Clinic
Cleveland, United States
75 h-index
734 publications
81.7K citations
University College London
London, United Kingdom
73 h-index
851 publications
95K citations

Biogen (United States)
Cambridge, United States
73 h-index
1.2K publications
151.5K citations
Heinrich Heine University Düsseldorf
Düsseldorf, Germany
68 h-index
779 publications
155.9K citations
Montreal Neurological Institute and Hospital
Montreal, Canada
65 h-index
422 publications
67.1K citations

McGill University
Montreal, Canada
64 h-index
349 publications
62.9K citations
1–8 of 5.4K
483 publications · 56.4K citations
129
h-index
MSJ · 801 publications · 42.7K citations
97
h-index
148 publications · 24.8K citations
83
h-index
162 publications · 12.2K citations
64
h-index
213 publications · 11.6K citations
59
h-index
1–5